Sign in
4

Changes in Ownership

BIOLARGO, INC. Filed Acc 0001437749-25-035504

Chief Science Officer acquired 313,754 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

CODE KENNETH REAY · Chief Science Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-14 Grant or award : show line 1 in the form +313,754 $0.16 $50,201 25,751,505 D
Loading xslF345X05/rdgdoc.xml…